GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India · Delayed Price · Currency is INR 2,578.10
-22.70 (-0.87%)
At close: Dec 15, 2025
NSE:GLAXO Market Cap
NSE:GLAXO has a market cap or net worth of 436.23 billion as of December 15, 2025. Its market cap has increased by 7.49% in one year.
Market Cap
436.23B
Enterprise Value
415.98B
Revenue
37.09B
Ranking
n/a
PE Ratio
45.67
Stock Price
2,578.10
Market Cap Chart
Since October 25, 2001, NSE:GLAXO's market cap has increased from 19.14B to 436.23B, an increase of 2,179.14%. That is a compound annual growth rate of 13.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 440.12B | 15.36% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | 274.98B | 0.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.31T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 934.94B |
| Mankind Pharma | 883.90B |
| Aurobindo Pharma | 694.12B |
| Alkem Laboratories | 673.27B |